These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 16882888

  • 1. Microarray analysis of gene expression during early stages of mild and severe cardiac hypertrophy.
    Rajan S, Williams SS, Jagatheesan G, Ahmed RP, Fuller-Bicer G, Schwartz A, Aronow BJ, Wieczorek DF.
    Physiol Genomics; 2006 Nov 27; 27(3):309-17. PubMed ID: 16882888
    [Abstract] [Full Text] [Related]

  • 2. Microarray analysis of active cardiac remodeling genes in a familial hypertrophic cardiomyopathy mouse model rescued by a phospholamban knockout.
    Rajan S, Pena JR, Jegga AG, Aronow BJ, Wolska BM, Wieczorek DF.
    Physiol Genomics; 2013 Sep 03; 45(17):764-73. PubMed ID: 23800848
    [Abstract] [Full Text] [Related]

  • 3. Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein.
    Gaffin RD, Peña JR, Alves MS, Dias FA, Chowdhury SA, Heinrich LS, Goldspink PH, Kranias EG, Wieczorek DF, Wolska BM.
    J Mol Cell Cardiol; 2011 Nov 03; 51(5):812-20. PubMed ID: 21840315
    [Abstract] [Full Text] [Related]

  • 4. Effects of nicotine administration in a mouse model of familial hypertrophic cardiomyopathy, α-tropomyosin D175N.
    Gaffin RD, Chowdhury SA, Alves MS, Dias FA, Ribeiro CT, Fogaca RT, Wieczorek DF, Wolska BM.
    Am J Physiol Heart Circ Physiol; 2011 Oct 03; 301(4):H1646-55. PubMed ID: 21743000
    [Abstract] [Full Text] [Related]

  • 5. Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis.
    Jagatheesan G, Rajan S, Petrashevskaya N, Schwartz A, Boivin G, Arteaga GM, Solaro RJ, Liggett SB, Wieczorek DF.
    Am J Physiol Heart Circ Physiol; 2007 Aug 03; 293(2):H949-58. PubMed ID: 17416600
    [Abstract] [Full Text] [Related]

  • 6. Decreasing tropomyosin phosphorylation rescues tropomyosin-induced familial hypertrophic cardiomyopathy.
    Schulz EM, Wilder T, Chowdhury SA, Sheikh HN, Wolska BM, Solaro RJ, Wieczorek DF.
    J Biol Chem; 2013 Oct 04; 288(40):28925-35. PubMed ID: 23960072
    [Abstract] [Full Text] [Related]

  • 7. Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade.
    Michele DE, Gomez CA, Hong KE, Westfall MV, Metzger JM.
    Circ Res; 2002 Aug 09; 91(3):255-62. PubMed ID: 12169652
    [Abstract] [Full Text] [Related]

  • 8. Ablation of plasma membrane Ca(2+)-ATPase isoform 4 prevents development of hypertrophy in a model of hypertrophic cardiomyopathy.
    Prasad V, Lorenz JN, Lasko VM, Nieman ML, Jiang M, Gao X, Rubinstein J, Wieczorek DF, Shull GE.
    J Mol Cell Cardiol; 2014 Dec 09; 77():53-63. PubMed ID: 25280781
    [Abstract] [Full Text] [Related]

  • 9. Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction.
    Muthuchamy M, Pieples K, Rethinasamy P, Hoit B, Grupp IL, Boivin GP, Wolska B, Evans C, Solaro RJ, Wieczorek DF.
    Circ Res; 1999 Jul 09; 85(1):47-56. PubMed ID: 10400910
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice.
    Prabhakar R, Boivin GP, Grupp IL, Hoit B, Arteaga G, Solaro RJ, Wieczorek DF.
    J Mol Cell Cardiol; 2001 Oct 09; 33(10):1815-28. PubMed ID: 11603924
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
    Szczesna-Cordary D, Guzman G, Zhao J, Hernandez O, Wei J, Diaz-Perez Z.
    J Cell Sci; 2005 Aug 15; 118(Pt 16):3675-83. PubMed ID: 16076902
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T.
    Maass AH, Ikeda K, Oberdorf-Maass S, Maier SK, Leinwand LA.
    Circulation; 2004 Oct 12; 110(15):2102-9. PubMed ID: 15466629
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T, Chung J, Doolan A, Nguyen L, Williams IA, Tu E, Lam L, Bailey CG, Rasko JE, Allen DG, Semsarian C.
    J Mol Cell Cardiol; 2006 Oct 12; 41(4):623-32. PubMed ID: 16950368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.